A Randomized Double-Blind Placebo-Controlled Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder of Moderate or Greater Severity
Brief description of study
The purpose of this research is to test the safety and effectiveness of MDMA-assisted psychotherapy for participants with Post traumatic Stress Disorder. MDMA is an experimental drug, which means that it has not been approved by the Food and Drug Administration (FDA) for sale for medical use in the United States (U.S.).
Clinical Study Identifier: s20-00305
ClinicalTrials.gov Identifier: NCT04077437
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
